In Vitro Diagnostic Rapid Test Reader

In Vitro Diagnostic Rapid Test Reader

Brand :Norman

Product origin :Nanjing

Delivery time :Two weeks after payment

Supply capacity :1000 units/month

In Vitro Diagnostic Rapid Test Reader
For POCT FIA (Fluorescence Immunoassay):
1. Extra incubator to provide Auto-incubating and Auto-alarm System.
2. Extra incubator to provide Isolated Incubation Environment to Eliminate Corruption.
3. Analysis in 10 seconds, CV < 10%
4. Extra incubator to provide Simultaneous incubation of 8 samples.
5. Whole blood samples for both PCT and hs-CRP.

In Vitro Diagnostic Rapid Test Reader


point of care diagnostics companies            Introduction:                                                                                                

NRM-FI-1000 Fluorescence Immunoassay Analyzer is a quantitative system which can accurately read and analyze the test results of the Fast Test Kits. It is a decent system for diagnosis and risk stratification of cardiovascular diseases, kidney disease, diabetes, bacteria or virus infection, etc and prognosis.


Test menu:

immunofluorescence assay analyzer

Features:
1. One incubator can incubate 8 samples simultaneous.
2. Incubators can be underlied together to imcubate more strips.
3. Constant incubation temperature:30ºC.
4. Automatically prompt after incubation , set up time from 5 to30 mins according to different assays.
5. Testing times:10s.
6. Sample type: whole blood, serum, plasma and urine.
7. Portable and practical: small, easy to carry and place.
8. Intelligent management: touch-screen control, can be connected to LIS and HIS system.
9. Application: outpatient, emergency, Medical Center, cardiology department, etc.


Parameter:                                                                                               

Power condition  

~ 220v±22V 50HZ±1Hz

Input power         

50VA

Repeatability

CV≤5%

Volume      

214mm×260mm×143mm


Certifications:CE /SGS/ISO13485/Free Sales Certification.


Test Cards:

poc testing

point of care diagnostics companies

Cardiovascular:CK-MB, NT-proBNP, D-Dimer, cTnI/CK-MB/MYO, cTnI, MYO 

Gastrosis: PGI, PGII

Inflammation/Infection:PCT(whole blood), PCT (serum),  hs-CRP+CRP(whole blood)

Nephropathy:B2-MG, NAGL, Cys-c, mAlb 

Diabetes:HbA1c

Upcoming: Vitamin D, T3/T4/TSH, mALb, β-HCG, SAA, Ferritin


Intended Use

The immunofluorescence quantitative analyzer is used with our dedicated kit for immunofluorescence test of human serum,plasma,whole blood and body fluid. It can be used in medical institutes’ centralab,emergency laboratory,clinical department,other medical services,(Like community medical centre),physical examination center and research laboratory.

 

Principle of the Instrument

The principle of chromatography is a kind of separation technologies based on using physical property differences from components in mixture. (Such as adsorption force, molecular size and shape, molecular polarity and molecular affinity, partition coefficient, etc.) Chromatography system consists of stationary phase and mobile phase. The stationary phase is solid substance or components fixed on solid substance while the mobile phase refers to the flowing materials, such as water or various solvents.

Chromatography process: when to-be-separated mixture goes through the stationary phasewith the mobile phase, due to the differences between the physical properties of various components in the mixture. Components that have weaker interaction with the stationary phase have the faster velocity because of the smaller blocking effect while components that have stronger interaction with the stationary phase have the slower velocity because of the larger blocking effect. In that case, components in mixture are separated.

Immune chromatography technology is a new immune test technology based on the chromatography and the specificity immune response of antigen and antibody.

Immune chromatography technology uses strip-shaped fibrous chromatography material fixed with test lines and control lines as the stationary phase and test liquid as the mobile phase, and the movement of determinands on the chromatography strips is realized by the capillary effect. Determinands’specific immunoreactions occur at line T while the free substances occur at line C.

immunofluorescence assay analyzer

Commonly-used immunofluorescence chromatography can be divided into competition approach and sandwich assay.Competition approach refers to the process that some kind of antigen in determinands as well as in line T competitively combines with fluorescently labeled antibodies.Sandwich assay is the process of the specifical combination of some kind of antibody (antigen) in determinands and antigen A (antibody A) with fluorescently labeled antigen B (antibody B). Fluorescence quantitative system mainly does analysis and processing on the testing card. Its principle isInsert the testing card into the immunofluorescence quantitative analyzer after reaction, and then the test system of the instrument automatically scans line T and line C to obtain the optical signals. After that, material concentration could be quantitatively calculated by measuring and analyzing the optical signals.

This instrument is based on modern optoelectronic technology and applied in the quantitative analysis of immune fluorescent reagent strips and, more importantly, could detect the related parameters of the human body samples for clinical auxiliary diagnosis.


About us:                                                                                     

Nanjing Norman Biological Technology Co., Ltd is dedicated to R&D and manufacturing of automated chemiluminescence system.  Founded in  2008, Norman biological  has been  upholding the idea  that R&D shapes future,and concentration determines success.Ever since the beginning,Norman has been focusing on developing and manufacturing  chemiluminescence and  immunofluorescence  instruments and reagents.

Norman's manufacture center is located in the Yuhua District and owns an over 2,000m2GMPapproved clean workshop. The R&D base, which is over 2,000m2 , is located in state-level new  Jiangbei district. Now there are over 100 R&D engineers, 40% of which hold a PhD or master's degree.

Powered by advanced technology and excellent talents in the IVD field, Norman has been  consistently improving its innovation platform , and increasing R&D investment.Norman's  R&D  field  has  covered  instruments, reagents, and raw materials,and has been entrusted by the Nanjing government to build a R&D center specialized in biological chemistry and immunity diagnosis. Up to now, Norman has acquired over 20 patents.

Being an expert in automated chemiluminescence analysis ,Norman owns independent and completed intellectual property rights, and its products provide top-notch sensitivity,precision and accuracy.Thanks to the self-developed antigens and self-manufactured antibodies,Norman's products features minimized intra-and inter- batch difference.

After 8 years development, Norman is now on the fast track. An over 30,000m2 global R&D center is in construction,will hold more than1,000 R&D engineers in the future.R&D shapes future,and concentration determines success. Driven by the commitment to "provide complete solution to improve human health", Norman will consistently do its utmost to drive the IVD industry forward and contribute more to human health.

poc testing

point of care diagnostics companies

Agent Wanted: If you are interested in working with us, please feel free to contact. 


immunofluorescence assay analyzer    

Why Us:                                                                                                                

1. Manufacturer and Exporter for nearly 10 years with self R&D Research Center;

2. Professional After-Sale service with On-site support worldwide; 

3. CE/ISO13485/SGS/RoHS Certifications!


OEM and ODM are available !


Please feel free to give your inquiry in the form below. We will reply you in 24 hours.